Print

Licensed to Catalyze

Elevance broadens technology portfolio with XiMo’s catalysts
By Bryan Sims | March 18, 2011

Elevance Renewable Sciences Inc. added XiMo AG to its list of strategic partners as the Bolingbrook, Ill.-based bioscience firm signed a licensing agreement with XiMo to use its proprietary molybdenum and tungsten metathesis catalysts with natural oils. XiMo will work exclusively with Elevance in the natural oils field during the term of a collaborative research program between the parties.

According to Andy Schafer, Elevance’s vice president of sales and market development, the addition of XiMo’s catalysts will bolster Elevance’s existing portfolio of metathesis catalysts, such as ruthenium, and is expected to expand the company’s capabilities of delivering value-added solutions to a broader set of customers utilizing renewable feedstocks.

“The catalysts from XiMo represent a different class of metathesis catalysts than what has been available in commercial quantities before,” Schafer tells Biorefining Magazine. “We want to make sure that we assess where these new catalysts can fit and help us achieve things that we couldn’t do with our current slate of catalysts.”

XiMo’s catalysts are based on breakthrough scientific research of founders Amir Hoveyda and Richard Schrock.

“We look forward to working with Elevance to develop novel materials, processes and products in the natural oil field using XiMo technology,” says XiMo CEO Georg Frater. “Our goal is to find catalysts that will decrease cost and increase efficiency of production of our customers’ products.”

In addition to XiMo, Elevance has strategic partnerships with Wilmar International Ltd., Stepan Co., Cargill Inc., Dow Corning Corp., Trent University, Tetramer Technologies, United Soybean Board and SaskCanola. 

—Bryan Sims

 

0 Responses

     

    Leave a Reply

    Biomass Magazine encourages encourages civil conversation and debate. However, we reserve the right to delete comments for reasons including but not limited to: any type of attack, injurious statements, profanity, business solicitations or other advertising.

    Comments are closed